- Home
- GDDY vs ASND Comparison
GDDY vs ASND Comparison
Compare GDDY & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GDDY | ASND |
|---|---|---|
| Founded | 1997 | 2006 |
| Country | United States | Denmark |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.7B | 13.0B |
| IPO Year | 2014 | 2014 |
Fundamental Metrics
Financial Performance| Metric | GDDY | ASND |
|---|---|---|
| Price | $77.00 | $223.05 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 16 | 16 |
| Target Price | $136.44 | ★ $281.50 |
| AVG Volume (30 Days) | ★ 2.2M | 511.5K |
| Earning Date | 04-30-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.60 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $7.94 | $96.35 |
| Revenue Next Year | $6.10 | $44.91 |
| P/E Ratio | $48.43 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $71.59 | $161.09 |
| 52 Week High | $181.49 | $250.74 |
Technical Indicators
Market Signals| Indicator | GDDY | ASND |
|---|---|---|
| Relative Strength Index (RSI) | 36.45 | 48.81 |
| Support Level | $73.06 | $213.28 |
| Resistance Level | $93.09 | $236.58 |
| Average True Range (ATR) | 4.18 | 8.62 |
| MACD | -1.33 | -0.34 |
| Stochastic Oscillator | 22.88 | 53.39 |
Price Performance
Historical ComparisonAbout GDDY GoDaddy Inc.
GoDaddy Inc provides digital solutions and services for entrepreneurs, small businesses, individuals, organizations, developers, designers, and domain investors. It offers tools intended to support business creation and management through an integrated service platform. The company operates through two segments: Applications and Commerce (A&C) and Core Platform (Core). The majority of the company's revenue is derived from the Core Platform segment, which consists of sales of domain registrations and renewals, aftermarket domain sales, website hosting products and website security products. Geographically, it generates the maximum revenue from the United States.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, and others. It operates in the United States, Europe, and the rest of the world and derives the majority of its revenue from the United States.